retatrutide trial results today Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released phase 2 demonstrating 25% weight loss in half of people with #obesity. This amount of weight loss has not been accomplished Could GLP-1 drugs be Flavor:Original 🌱 LOCATION_UK

retatrutide trial results today Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released phase 2 demonstrating 25% weight loss in half of people with #obesity. This amount of weight loss has not been accomplished Could GLP-1 drugs be Flavor:Original 🌱 LOCATION_UK

Could GLP-1 drugs be used to fight Alzheimer's disease? Dr. Eric Topol, author of “Super Agers,” explains the possibilities. #Amanpour #AmanpourPBS #pbs

Formulary Change Some brands like Vyvanse are excluded from the Performance Formulary due to the availability of generic alternatives

LOCATION_UK

Flavor:Original 🌱

Something to keep in mind is that research into GLP-1’s effect on consuming alcohol is still being conducted